CAS: 5867-98-1; Diamyl Sulfate

相似化合物

142-31-4 625-22-9 598-05-0

上下游产品

CAS号2051-05-0 亚硫酸二戊酯 | CAS号71-41-0 正戊醇 | CAS号621-78-3 三正硼酸戊酯 | CAS号693-65-2 正戊醚 | CAS号2050-04-6 (PENTYLOXY)BENZENE

📜三正硼酸戊酯置于硫酸体系中,化学反应生成 硫酸二戊酯
参考文献:脂肪族硫醚通过三烷基硼酸盐对硫醇进行烷基化
标题:脂肪族硫醚通过三烷基硼酸盐对硫醇进行烷基化
摘要:描述了一种通过硼酯合成硫醚的简单方便的一锅法.该过程包括通过硼酸三烷基酯与浓硫酸的反应以及随后在吡啶存在下与硫醇的反应原位反应生成烷基硫酸盐.与伯醇或仲醇硼酯的反应在 100oc 下进行,并在 24 小时内以合理的产率 (59-93%) 提供脂肪族硫醚.有趣的是,产物的 1H NMR 谱没有显示位置异构的迹象.然而,由于苯环上的亲电取代,该方法对苯硫酚失败并且不会产生芳族硫醚.
DOI:10.1080/10426500903213563

专利信息

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人：YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:WO-2014011120-A1
优先权日:2012-07-13
标 题 :Endoperoxides, synthesis and uses thereof for the treatment of neoplastic diseases such as cancer
发明人：TAN NGUAN SOON; CHIBA SHUNSUKE
权利人:UNIV NANYANG TECH
摘要:The present invention generally relates to processes and methods for the synthesis of endoperoxide compounds. More specifically, the invention relates to a method for preparing endoperoxide compounds starting from an aryl imine of formula (I) in the presence of a metallic catalyst and oxygen. The present invention also relates to endoperoxide compounds of formula (III) and their pharmaceutically acceptable salts thereof, useful for therapy. All substituents are defined herein. Also disclosed are methods of treating cancer using the compounds of formula (III).

专利号:US-2001047100-A1
优先权日:2000-04-26
标 题:Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
发明人：KJAERSGAARD HANS JOERGEN; PHILLIPS JIM; ALI SYED M
摘要:Novel intermediates useful in the preparation of optically active H 3 histamine receptor antagonist 2-(4-imidazoyl)-cyclopropyl derivatives are disclosed.

专利号:US-2025049791-A1
优先权日:2023-08-03
标题:Synthesis of MEK7 Inhibitors and methods of Use Thereof
发明人：SCHEIDT KARL A; KIM DALTON ROBERT; ORR MEGHAN JO
权利人:UNIV NORTHWESTERN
摘要:Disclosed herein are 4-phenoxypyrimidine compounds and derivatives thereof for use as inhibitors of mitogen-activated protein kinase 7 (MEK7). The disclosed compounds and pharmaceutical compositions thereof may be used in methods for treating a disease or disorder associated with MEK7 activity, including cell proliferative diseases and disorders associated with MEK7 activity, such as cancer.

专利号:US-2006069270-A1
优先权日:2004-09-27
标 题 :Process for the preparation of 1,3,5-trisubstituted pyrazoles via [3+2] cycloaddition
发明人：SHAPIRO RAFAEL; ROSSANO LUCIUS T; TENHUISEN KAREN L
权利人:SHAPIRO RAFAEL; ROSSANO LUCIUS T; TENHUISEN KAREN L
摘要:A process for the preparation of 1,3,5-trisubstituted pyrazole compounds, which are useful intermediates in the synthesis of factor Xa inhibitors.

专利号:US-8691972-B2
优先权日:2009-05-29
标 题 :Compounds and synthesis of tellurium-derivatized oligonucleotides for structural and functional studies
发明人：HUANG ZHEN
权利人:HUANG ZHEN
摘要:Disclosed are compounds of formula (I), a derivative, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer. Also disclosed are methods of preparing compound of formula (I), a derivative, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer. Further disclosed are methods of counducting drug discovery and research comprises applying the compound of formula (I), a derivative, or a tautomer thereof, or a pharmaceutically acceptable salt of said compound or said tautomer in an investigation.